Seyed Nasser Ostad Selected Research

Seyed Nasser Ostad Research Topics

Disease

44	Neoplasms (Cancer) 09/2022 - 01/2009
18	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2009
4	Poisoning 05/2022 - 03/2016
4	Cardiotoxicity 12/2021 - 09/2010
4	Colonic Neoplasms (Colon Cancer) 06/2017 - 11/2010
4	Breast Ductal Carcinoma 09/2016 - 01/2012
3	Carcinoma (Carcinomatosis) 09/2013 - 01/2012
2	Wounds and Injuries (Trauma) 01/2021 - 12/2016
2	Neoplasm Metastasis (Metastasis) 11/2020 - 01/2019
2	Hypoxia (Hypoxemia) 11/2020 - 09/2010
2	Testicular Neoplasms (Testicular Cancer) 01/2020 - 07/2019
2	Inflammation (Inflammations) 07/2019 - 07/2012
2	Leukemia 01/2019 - 09/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2018 - 11/2015
2	Necrosis 03/2016 - 08/2014
2	Edema (Dropsy) 01/2014 - 07/2012
2	Colorectal Neoplasms (Colorectal Cancer) 01/2014 - 11/2010
2	Fibrosarcoma 06/2013 - 12/2010
2	Adenocarcinoma 01/2012 - 09/2010
1	Heart Injuries 05/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 11/2020
1	Left Ventricular Dysfunction 04/2020
1	Sickle Cell Anemia (Hemoglobin S Disease) 02/2020
1	Aplastic Anemia (Anemia, Hypoplastic) 02/2020
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 02/2020
1	beta-Thalassemia (Cooley's Anemia) 02/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Transitional Cell Carcinoma 01/2020
1	Endometriosis 07/2019
1	Prostatic Neoplasms (Prostate Cancer) 07/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2018

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 02/2021 - 12/2010
4	aluminum phosphideIBA 05/2022 - 03/2016
4	CannabinoidsIBA 01/2019 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2010
3	AntioxidantsIBA 08/2020 - 01/2012
3	Trastuzumab (Herceptin)FDA Link 04/2020 - 01/2011
3	AntigensIBA 01/2020 - 01/2011
3	Irinotecan (Camptosar)FDA LinkGeneric 05/2017 - 01/2014
3	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2015 - 09/2010
3	Cyclin EIBA 01/2015 - 09/2013
3	Polylactic Acid-Polyglycolic Acid CopolymerIBA 08/2014 - 01/2011
3	Docetaxel (Taxotere)FDA Link 06/2014 - 08/2009
3	methotrexate-serum albuminIBA 09/2012 - 01/2011
2	Cisplatin (Platino)FDA LinkGeneric 09/2022 - 01/2020
2	phosphine (phosphane)IBA 12/2021 - 03/2016
2	Biological ProductsIBA 01/2021 - 10/2018
2	Protein CoronaIBA 02/2020 - 01/2020
2	GoldIBA 01/2020 - 06/2017
2	Phosphotransferases (Kinase)IBA 10/2018 - 06/2018
2	Biotin (Vitamin H)FDA Link 05/2017 - 12/2011
2	ethyl acetateIBA 09/2016 - 01/2012
2	Chloroform (Trichloromethane)IBA 09/2016 - 01/2012
2	AlkaloidsIBA 02/2015 - 01/2015
2	PapaverineIBA 02/2015 - 01/2015
2	Noscapine (Narcotine)IBA 02/2015 - 01/2015
2	OpiumIBA 02/2015 - 01/2015
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2015 - 09/2010
2	Protein Isoforms (Isoforms)IBA 01/2015 - 09/2010
2	CarrageenanIBA 01/2014 - 07/2012
2	Methotrexate (Mexate)FDA LinkGeneric 09/2013 - 12/2011
2	Formaldehyde (Formol)FDA Link 07/2012 - 09/2010
2	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2010 - 01/2009
2	DNA (Deoxyribonucleic Acid)IBA 09/2010 - 04/2010
1	Metformin (Glucophage)FDA LinkGeneric 09/2022
1	CannabidiolIBA 05/2022
1	Exenatide (Byetta)FDA Link 12/2021
1	Biopolymers (Biopolymer)IBA 01/2021
1	bisphenol AIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	HydrogelsIBA 11/2020
1	CurcuminIBA 11/2020
1	Carvedilol (Coreg)FDA LinkGeneric 04/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	human PLAC1 proteinIBA 01/2020
1	CateninsIBA 01/2020
1	Cytidine Triphosphate (CTP)IBA 07/2019
1	PhycoerythrinIBA 02/2019
1	StreptavidinIBA 02/2019
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Histidine (L-Histidine)FDA Link 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	AM 251 (AM251)IBA 01/2019
1	pyreneIBA 01/2019
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2019
1	IntegrinsIBA 01/2019
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2019
1	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 01/2019
1	CB2 Cannabinoid ReceptorIBA 01/2019
1	EndocannabinoidsIBA 01/2019
1	withaferin AIBA 10/2018

Therapy/Procedure

12	Therapeutics 09/2022 - 12/2010
9	Drug Therapy (Chemotherapy) 09/2022 - 12/2011
3	Immunotherapy 01/2020 - 06/2013
3	Transplantation 11/2018 - 08/2013
1	Mastectomy (Mammectomy) 01/2021
1	Mammaplasty (Breast Reconstruction) 01/2021